Beryl Capital Management LLC 13D and 13G filings for Marinus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-07 7:15 pm Purchase |
2024-12-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Beryl Capital Management LLC | 5,462,942 9.900% |
5,462,942 (New Position) |
Filing |